- About Us
- News & Events
- Get Information
- Our Research
- Treatment Trials
Dr Natalie Thomas
Dr Natalie Thomas Bsc(Hons) PhD
Dr Thomas joined the Women’s Mental Health Team at MAPrc in May 2016. She completed
a Bachelor of Science withHonours at The University of Melbourne in 2008, majoring in biochemistry and molecular biology. Her interest in mental health on a human level, and perception and decision-making on a philosophical level, saw her commence her doctoral studies in molecular psychiatry within the Department of Psychiatry at the University of Melbourne. She graduated in early 2016, with her doctoral thesis titled “Investigation of potential subgroups within the schizophrenias: A study of cholinergic muscarinic receptor density and energy metabolism”. This work allowed for progress toward clinically useful biomarkers.
Dr Thomas’ interest lies at the intercept of psychology and biology. She aims to further our understanding in psychiatric biological markers, particularly within the area of psychoneuroendocrinology, and treatment response. She asserts the importance of working within a collaborative research centre that considers biological, social, and psychological factors simultaneously, and feels extremely fortunate to be working within a research centre that follows such a practice.
Dr Thomas is currently involved in several ongoing clinical trials at MAPrc, including research examining the effect of tibolone, a hormone therapy in menopausal women with depression, the potential use of a selective estrogen receptor modulator (SERM) to alleviate symptoms of schizophrenia, and also the effect of memantine, a drug currently used in Alzheimer’s, to improve symptoms experienced in people suffering with borderline personality disorder (BPD).